(Q37598171)

21 August 2017

1 reference

title

Pharmacological targeting of CDK9 in cardiac hypertrophy (English)

1 reference

21 August 2017

1 reference

3

Radek Jorda

1 reference

21 August 2017

Vladimír Krystof

1

1 reference

PubMed ID

19757441

21 August 2017

Ivo Chamrád

series ordinal

2

1 reference

PubMed ID

19757441

21 August 2017

Jirí Kohoutek

series ordinal

4

1 reference

21 August 2017

1 July 2010

1 reference

Medicinal Research Reviews

21 August 2017

1 reference

21 August 2017

30

1 reference

21 August 2017

646-666

1 reference

21 August 2017

4

1 reference

Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure

21 August 2017

1 reference

Protein kinase cascades in the regulation of cardiac hypertrophy

21 January 2018

1 reference

A Ras-dependent pathway regulates RNA polymerase II phosphorylation in cardiac myocytes: implications for cardiac hypertrophy

21 January 2018

1 reference

Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors

21 January 2018

1 reference

Flavopiridol inhibits smooth muscle cell proliferation in vitro and neointimal formation In vivo after carotid injury in the rat

21 January 2018

1 reference

The cyclin-dependent kinase inhibitor seliciclib (R-roscovitine; CYC202) decreases the expression of mitotic control genes and prevents entry into mitosis

21 January 2018

1 reference

B5, a novel pyrrole-substituted indolinone, exerts potent antitumor efficacy through G2/M cell cycle arrest

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MED.20172

1 reference

21 August 2017

1 reference

PubMed ID

19757441